Citigroup’s Osiris Therapeutics, Inc. Common Stock OSIR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q2 | – | Sell |
-41,476
| Closed | -$788K | – | 5306 |
|
|
2019
Q1 | $788K | Buy |
+41,476
| New | +$788K | ﹤0.01% | 2156 |
|
|
2017
Q1 | – | Sell |
-20,007
| Closed | -$98K | – | 5071 |
|
|
2016
Q4 | $98K | Sell |
20,007
-2,270
| -10% | -$11.1K | ﹤0.01% | 3913 |
|
|
2016
Q3 | $110K | Buy |
22,277
+10,661
| +92% | +$52.6K | ﹤0.01% | 3352 |
|
|
2016
Q2 | $59K | Sell |
11,616
-8,399
| -42% | -$42.7K | ﹤0.01% | 3625 |
|
|
2016
Q1 | $114K | Buy |
20,015
+6,665
| +50% | +$38K | ﹤0.01% | 3874 |
|
|
2015
Q4 | $138K | Buy |
13,350
+9,849
| +281% | +$102K | ﹤0.01% | 3335 |
|
|
2015
Q3 | $65K | Sell |
3,501
-5,503
| -61% | -$102K | ﹤0.01% | 3409 |
|
|
2015
Q2 | $175K | Buy |
9,004
+3,476
| +63% | +$67.6K | ﹤0.01% | 2835 |
|
|
2015
Q1 | $98K | Sell |
5,528
-13,045
| -70% | -$231K | ﹤0.01% | 3419 |
|
|
2014
Q4 | $297K | Buy |
18,573
+7,990
| +75% | +$128K | ﹤0.01% | 2871 |
|
|
2014
Q3 | $133K | Sell |
10,583
-377
| -3% | -$4.74K | ﹤0.01% | 2927 |
|
|
2014
Q2 | $171K | Sell |
10,960
-11,579
| -51% | -$181K | ﹤0.01% | 2703 |
|
|
2014
Q1 | $296K | Buy |
22,539
+4,014
| +22% | +$52.7K | ﹤0.01% | 2532 |
|
|
2013
Q4 | $298K | Buy |
18,525
+9,098
| +97% | +$146K | ﹤0.01% | 2797 |
|
|
2013
Q3 | $158K | Buy |
9,427
+9,237
| +4,862% | +$155K | ﹤0.01% | 2793 |
|
|
2013
Q2 | $2K | Buy |
+190
| New | +$2K | ﹤0.01% | 4944 |
|